Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 1,801	$ 252
Inventory	8,419	10,128
Total Current Assets	10,220	10,380
Patents	0	0
TOTAL ASSETS	10,220	10,380
CURRENT LIABILITIES
Accounts payable	787,152	609,505
Accounts payable and accrued expenses related party	373,849	222,738
Accrued expenses	199,458	106,982
Convertible note payable (net of debt discount)	543,004	497,951
Total Current Liabilities	1,903,463	1,437,176
Longterm Liabilities
PPP Loan	95,485	201,352
Total longterm liabilities	95,485	201,352
Total Liabilities	1,998,948	1,638,528
Commitments and Contingencies	0	0
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; $0.0001 par value, 35,000,000 shares authorized, 10,000,000 shares issued and outstanding as of December 31, 2021 and December 31, 2020 respectively	1,000	1,000
Common stock; $0.0001 par value, 465,000,000 shares authorized, 98,971,300 and 84,738,300 issued and outstanding as of December 31, 2021 and December 31, 2020	9,896	8,472
Shares to be issued	5,000	13,803
Additional paid-in capital	2,585,308	2,069,582
Accumulated deficit	(4,589,932)	(3,721,005)
Total Stockholders' Equity (Deficit)	(1,988,728)	(1,628,148)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 10,220	$ 10,380